Evidence map›Paper›PMID 28484421›Full record

ArticleFrontiers in neurology2017

The Randomized Controlled STRAWINSKI Trial: Procalcitonin-Guided Antibiotic Therapy after Stroke.

Lena Ulm, Sarah Hoffmann, Darius Nabavi, Marcella Hermans, Bruno-Marcel Mackert, Frank Hamilton, Ingo Schmehl, Gerhard-Jan Jungehuelsing, Joan Montaner, Alejandro Bustamante and 9 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01264549 (Stroke Adverse Outcome is Associated With Nosocomial Infections), which is not on this map. Cited by 26 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 3 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01264549 nacompletednot on this map

Stroke Adverse Outcome is Associated With Nosocomial Infections: PCTus- Guided Antibacterial Therapy in Severe Ischemic Stroke Patients

TypeinterventionalSponsorCharite University, Berlin, GermanyRan2010 to 2014Enrolled230ConditionsIschemic StrokeArmsProcalcitonin assay - B.R.A.H.M.S PCT ultrasensitive Kryptor
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 3 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Antibiotic therapy for preventing infections in people with acute stroke.The Cochrane database of systematic reviews · 2018
    Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 4 countries.

Lena UlmNeuroCure Clinical Research Center, Charité - Universitaetsmedizin Berlin, Berlin, Germany.
Sarah HoffmannNeuroCure Clinical Research Center, Charité - Universitaetsmedizin Berlin, Berlin, Germany.
Darius NabaviDepartment of Neurology, Vivantes Klinikum Neukoelln, Berlin, Germany.
Marcella HermansDepartment of Neurology, Vivantes Klinikum Neukoelln, Berlin, Germany.
Bruno-Marcel MackertDepartment of Neurology, Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany.
Frank HamiltonDepartment of Neurology, Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany.
Ingo SchmehlDepartment of Neurology, Unfallkrankenhaus Berlin, Berlin, Germany.
Gerhard-Jan JungehuelsingDepartment of Neurology and Center for Stroke Research Berlin, Charité - Universitaetsmedizin Berlin, Berlin, Germany.
Joan MontanerNeurovascular Research Laboratory, Institut de Recerca, Hospital Universitari Vall d'Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain.
Alejandro BustamanteNeurovascular Research Laboratory, Institut de Recerca, Hospital Universitari Vall d'Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain.
Mira KatanDepartment of Neurology, Universitaetsspital Zuerich, Zurich, Switzerland.
Andreas HartmannDepartment of Neurology, Klinikum Frankfurt Oder, Frankfurt Oder, Germany.
Stefan EbmeyerThermo Fisher Scientific BRAHMS GmbH, Hennigsdorf, Germany.
Christiane DinterThermo Fisher Scientific BRAHMS GmbH, Hennigsdorf, Germany.
Jan C WiemerThermo Fisher Scientific BRAHMS GmbH, Hennigsdorf, Germany.
Sabine HertelThermo Fisher Scientific BRAHMS GmbH, Hennigsdorf, Germany.
Christian MeiselDepartment of Immunology, Charité - Universitaetsmedizin Berlin, Berlin, Germany.
Stefan D AnkerDivision of Innovative Clinical Trials, Department of Cardiology and Pneumology, University Medical Centre Goettingen, Goettingen, Germany.
Andreas MeiselNeuroCure Clinical Research Center, Charité - Universitaetsmedizin Berlin, Berlin, Germany.
Charité - Universitätsmedizin Berlin · DEThermo Fisher Scientific (Germany) · DEAuguste-Viktoria-Klinik · DEVall d'Hebron Institut de Recerca · ESVivantes Klinikum · DEIstituti di Ricovero e Cura a Carattere Scientifico · ITJüdisches Krankenhaus Berlin · DEKlinikum Frankfurt Höchst · DEUnfallkrankenhaus Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPneumonia is among the most common acute complications after stroke and is associated with poor long-term outcome. Biomarkers may help identifying stroke patients at high risk for developing stroke-associated pneumonia (SAP) and to guide early treatment.

aimsThis trial investigated whether procalcitonin (PCT) ultrasensitive (PCTus)-guided antibiotic treatment of SAP can improve functional outcome after stroke.

methodsIn this international, multicenter, randomized, controlled clinical trial with blinded assessment of outcomes, patients with severe ischemic stroke in the middle cerebral artery territory were randomly assigned within 40 h after symptom onset to PCTus-based antibiotic therapy guidance in addition to stroke unit care or standard stroke unit care alone. The primary endpoint was functional outcome at 3 months, defined according to the modified Rankin Scale (mRS) and dichotomized as acceptable (≤4) or unacceptable (≥5). Secondary endpoints included usage of antibiotics, infection rates, days of fever, and mortality. The trial was registered with http://ClinicalTrials.gov (Identifier NCT01264549).

resultsIn the intention-to-treat-analysis based on 227 patients (112 in PCT and 115 in control group), 197 patients completed the 3-month follow-up. Adherence to PCT guidance was 65%. PCT-guided therapy did not improve functional outcome as measured by mRS (odds ratio 0.79; 95% confidence interval 0.45-1.35,

conclusionPCTus-guided antibiotic therapy did not improve functional outcome at 3 months after severe ischemic stroke. PCT is a promising biomarker for early detection of pneumonia and sepsis in acute stroke patients.

Indexed as

antibiotic prophylaxisbiomarker-guided treatmentinfectionsoutcomepneumoniaprocalcitoninstroke

Identifiers

PMID28484421
PMCPMC5402305
OpenAlexW2608403661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.